Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
Vertex Pharmaceuticals beat earnings, with revenues hitting US$2.7b, ahead of expectations, and statutory earnings per share outperforming analyst reckonings by a solid 14%. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year. View our latest analysis for Vertex Pharmaceuticals Following the latest results, Vertex Pharmaceuticals' 30 analysts are now forecasting revenues of US$10.8b in 2024. This would be a credible 5.7% improvement in revenue compared to the last 12 months. Statutory earnings per share are forecast to dip 2.8% to US$15.13 in the same period. In the lead-up to this report, the analysts had been modelling revenues of US$10.7b and earnings per share (EPS) of US$14.90 in 2024. The consensus analysts don't seem to
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. [Yahoo! Finance]Yahoo! Finance
- Jennifer Schneider Elected to Vertex Board of Directors [Yahoo! Finance]Yahoo! Finance
- Jennifer Schneider Elected to Vertex Board of DirectorsBusiness Wire
- Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 5/6/24 - Beat
VRTX
Sec Filings
- 5/20/24 - Form 8-K
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- VRTX's page on the SEC website